M 315
Pill imprint M 315 has been identified as Ondansetron hydrochloride 4 mg.
Ondansetron is used in the treatment of nausea/vomiting; nausea/vomiting, chemotherapy induced; gastroenteritis; nausea/vomiting, postoperative; obsessive compulsive disorder (and more), and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy.
Ondansetron 4 mg is not subject to the Controlled Substances Act.
See also related documents.
Ondansetron hydrochloride Images
- Imprint:
-
M
315 - Strength:
- 4 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
croscarmellose sodium
hypromellose
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
corn starch
sodium lauryl sulfate
titanium dioxide
triacetin
- Drug Class:
- 5HT3 receptor antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0315
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0524 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
Advertisement
More Ondansetron Hydrochloride resources
- Ondansetron
- Ondansetron (Wolters Kluwer)
- Ondansetron Orally Disintegrating Tablets (Wolters Kluwer)
- Ondansetron Soluble Film (Wolters Kluwer)
- Ondansetron Solution (Wolters Kluwer)
- Ondansetron Tablets (Wolters Kluwer)
- ondansetron (Cerner Multum)
- ondansetron injection (Cerner Multum)
- ondansetron Oral, Injection, Intravenous (Micromedex) - Includes Dosage Information
- ondansetron Oral, Oromucosal (Micromedex) - Includes Dosage Information
- Ondansetron Hydrochloride (AHFS DI)
- Ondansetron (FDA)
- Ondansetron Injection (FDA)
- Ondansetron ODT (FDA)
- Ondansetron Oral Solution (FDA)
- Ondansetron and Dextrose (FDA)
- Zofran Injection (FDA)
- Ondansetron Hydrochloride (Wolters Kluwer)
Search Again
